FIELD: medicine, pharmaceutics. SUBSTANCE: innovation deals with pharmaceutical composition of diuretic, dehydrating and hypotensive action in tabletted form, including hydrochlorothiazide and additional substances. It is, also, distinguished by the fact that it additionally contains 4-amino-6-chlorobenzene-1,3- disulfonamide at the following ratio of components, wt. %: hydrochlorothiazide, 17.8-20.7; 4-amino-6- chlorobenzene-1,3-disulfonamide, 0.05-0.2; microcrystalline cellulose, 24.6-28.7; magnesium stearate 0.8-1.0; potato starch, 7.0-8.3; lactose, the balance. Pharmaceutical composition of the present innovation manifests more pronounced diuretic action being stable at storage. EFFECT: higher efficiency. 2 ex, 1 tbl
